UPB
Price:
$9.19
Market Cap:
$500.12M
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.
Industry
Biotechnology
IPO Date
2024-10-11
Stock Exchange
NASDAQ
Ticker
UPB
According to Upstream Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 399.81M. This represents a change of -48.76% compared to the average of 780.24M of the last 4 quarters.
The mean historical Enterprise Value of Upstream Bio, Inc. over the last ten years is 859.32M. The current 399.81M Enterprise Value has changed 4.55% with respect to the historical average. Over the past ten years (40 quarters), UPB's Enterprise Value was at its highest in in the December 2025 quarter at 1.37B. The Enterprise Value was at its lowest in in the September 2023 quarter at 0.
Average
859.32M
Median
777.74M
Minimum
520.00M
Maximum
1.36B
Discovering the peaks and valleys of Upstream Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 161.88%
Maximum Annual Enterprise Value = 1.36B
Minimum Annual Increase = -32.76%
Minimum Annual Enterprise Value = 520.00M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.36B | 161.88% |
| 2024 | 520.00M | -32.76% |
| 2023 | 773.33M | -1.13% |
The current Enterprise Value of Upstream Bio, Inc. (UPB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
885.04M
5-year avg
859.32M
10-year avg
859.32M
Upstream Bio, Inc.’s Enterprise Value is less than Zenas BioPharma, Inc. (752.80M), less than Intellia Therapeutics, Inc. (1.41B), less than Wave Life Sciences Ltd. (798.32M), less than Relay Therapeutics, Inc. (2.20B), less than Pharvaris N.V. (1.37B), less than Syndax Pharmaceuticals, Inc. (2.03B), less than Novavax, Inc. (1.31B), less than Amylyx Pharmaceuticals, Inc. (1.08B), less than Terns Pharmaceuticals, Inc. (4.24B), less than Spyre Therapeutics, Inc. (4.26B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 752.80M | $783.48M | |
| 1.41B | $1.47B | |
| 798.32M | $1.33B | |
| 2.20B | $2.25B | |
| 1.37B | $1.95B | |
| 2.03B | $1.82B | |
| 1.31B | $1.30B | |
| 1.08B | $1.30B | |
| 4.24B | $4.77B | |
| 4.26B | $4.34B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Upstream Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Upstream Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Upstream Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Upstream Bio, Inc. (UPB)?
What is the 3-year average Enterprise Value for Upstream Bio, Inc. (UPB)?
What is the 5-year average Enterprise Value for Upstream Bio, Inc. (UPB)?
How does the current Enterprise Value for Upstream Bio, Inc. (UPB) compare to its historical average?